FedCircuitBlog

Federal Circuit Judges Signal Support for Facebook Patent Win – On BloombergLaw.com, Perry Cooper reports that judges of the Federal Circuit “appear to agree with Facebook Inc. that [certain] patents . . . are invalid as abstract.”

Fed Circ Probes Validity of Cancer Treatment Patent from $1.2 Bln Win – Blake Brittain reports for Reuters that a panel of judges for the Federal Circuit “grilled [attorneys] on the validity of a cancer treatment patent that netted them nearly $1.2 billion.”

En Banc: When Employees Leave with a Half-Baked Invention – On PatentlyO.com, Dennis Crouch discusses Bio-Rad Laboratories, Inc. v. International Trade Commission and the case’s pending petition for rehearing en banc.

Federal Circuit Tears Up Road Map for Keeping Patent Cases in Texas – Scott Graham posted an article on Law.com reporting on how the Federal Circuit “ordered [Western District of Texas Judge] Albright to transfer patent actions brought by Ikorongo Technology LLC against Samsung Electronics and LG Electronics.”

District Court Thwarts $100 Million Damages Award, Finding Litigation Conduct Exceptional – On IPWatchDog, Gene Quinn writes about a long, drawn-out patent infringement battle that “saw action in front of a jury, at the district court, at the PTAB, at the Federal Circuit, and even . . . the Supreme Court.”

Oracle Files Yet Another JEDI Challenge with the U.S. Supreme Court – Sebastian Moss on DataCenterDynamics.com reports that the “US military appears trapped in an endless conflict with no clear winner.”

Performance-Based Actions: How Much Is Too Much? – In an article on FedSmith.com, Robbie Kunreuther reflects on a decision by the Federal Circuit concerning “unacceptable performance cases and how they should be addressed.”

This week and last the Supreme Court decided United States v. Arthrex, Inc. and Minerva Surgical, Inc. v. Hologic, Inc., two patent cases appealed from the Federal Circuit. Here is a report on recent articles and blog posts related to these cases.

USPTO Provides Guidance on Director Review Process Under Arthrex – On IPWatchDog, Eileen McDermott and Steve Brachmann write about how after the Arthrex decision the Patent and Trademark Office announced that it would implement the Supreme Court’s remedy using an interim rule that gives the Acting Director the authority to consider requests for reconsideration of final decisions made by the Patent Trial and Appeal Board.

What Will Arthrex Review Look Like? – Bradley Roush and George E. Quillin posted an article on the National Law Review raising questions many are having about how the Patent and Trademark Office will implement the new Director-led review process.

Justices Uphold a Narrow Version of Patent Assignor Estoppel – On SCOTUSBlog, Eric M. Fraser discusses how the Supreme Court reached its decision in Minerva narrowing the doctrine of assignor estoppel.

Professor Kagan v. Professor Barrett, Round 1 of N – On the Volokh Conspiracy, Josh Blackman posts about how in the Minerva case “two former professors were on opposite sides of the docket.”

CAFC Denies Amgen Petition to Reconsider Enablement Test for Biotech Patents – In an article on IPWatchDog, Logan Murr reports on the Federal Circuit’s denial of an en banc petition raising questions related to enablement filed by filed by Amgen Inc. in their case against Sanofi, Aventisub LLC. 

AWS Urges Supreme Court to Reject Oracle JEDI Review Petition – John Hewitt Jones writes for FedScoop.com about how “Amazon Web Services has filed a brief with the U.S. Supreme Court urging it to reject an earlier petition by Oracle to renew its challenge to the Pentagon’s $10 billion Joint Enterprise Defense Infrastructure (JEDI) contract.”

Federal Circuit Affirms Board Decision on Pandemic-Related Claim – On GovernmentContractsLegalForum.com, Steve McBrady, Charles Baek, Michelle Coleman, Rob Sneckenberg, John Nakoneczny, and Catherine Shames explain how the Federal Circuit “recently affirmed the Civilian Board of Contract Appeals’ (CBCA) decision denying a pandemic-related claim in Pernix Serka Joint Venture v. Secretary of State.”

Supreme Court Declines to Hear Cost Sharing Reduction Case – Susan Morse comments on HealthCareFinanceNews.com about how the Supreme Court will not hear a case decided by the Federal Circuit “regarding unpaid cost-sharing reduction payments to insurers.”

Justices Craft Their Own Remedy for Violation of Constitution’s Appointments Clause – George Quillin and Jeanne Gills post to SCOTUSblog about the Supreme Court’s decision this week in United States v. Arthrex.

Yu v. Apple Settles It: The CAFC is Suffering from a Prolonged Version of Alice in Wonderland Syndrome – Gene Quinn reports on IPWatchDog that “the Federal Circuit seems to be dealing with an exceptionally prolonged and worsening version of Alice in Wonderland syndrome.”

Amarin Rebuffed in High Court Bid to Revive Vascepa Patents – Susan Decker and Greg Stohr report for Bloomberg that the Supreme Court “declined to consider a bid by Amarin Corp. to revive six patents on the heart medicine Vascepa.”

Supreme Court Rebuffs Cost-Sharing Reduction Payment Appeal; $20 Million For State-Based Marketplaces – On HealthAffairs.org, Katie Keith notes “that two August decisions by a three-judge panel of the Court of Appeals for the Federal Circuit will stand.”

Yesterday the Senate Judiciary Committee voted 16-6 in favor of President Biden’s nomination of Tiffany P. Cunningham to the Federal Circuit. As a result, her nomination has advanced to the full Senate and has been placed on the Senate’s Executive Calendar.

American Axle is the Supreme Court’s Chance to Give Patent Eligibility a Tune-Up – On IPWatchDog.com, Dominic Frisina posts on the Supreme Court’s pending decision whether to review a Federal Circuit decision from 2020 related to patent eligibility.

Albright’s Delay in Patent Suit Not ‘Egregious,’ Fed. Cir. Says – Perry Cooper reports on how Freelancer failed to convince the Federal Circuit to order Judge Albright to act on its motion to dismiss in a patent case.

Patent Underlying Walker Process Claims is Not Enough to Give Rise to Federal Circuit Jurisdiction – Caitlin O’Connell and Elizabeth Ferrill write about the Federal Circuit’s decision to transfer a recent case to the United States Court of Appeals for the Fifth Circuit due to lack of jurisdiction. 

Fed. Circ. Won’t Allow ‘Focus Vision’ TM, Citing ‘Focus’ Marks – In an article on Law360.com, Tiffany Hu focuses on the Federal Circuit’s decision on Monday to uphold a Trademark and Appeal Board’s decision in a trademark case.

Federal Circuit affirms decision to toss iPhone dual-camera patent lawsuit – Mike Peterson posted a piece on AppleInsider.com discussing a recent win by Apple at the Federal Circuit on the issue of patent eligibility, where the court found patent claims to be directed to an abstract idea.

Alice Ax Of TV Patent Defied Precedent, Full Fed. Circ. Told – An article on Law360.com discussed a recent petition seeking rehearing on another decision by a Federal Circuit panel on the issue of patent eligibility, where the court also found patent claims to be directed to an abstract idea.

Piercing Halo’s Haze at Year Five: Smoke Clearing on Enhanced Damages – On IPWatchDog.com, Michael Cicero reports on the impact of the Supreme Court’s Halo decision on patentees.

Even Feds With Lifetime Tenure Can Be Fired for Cause, Court Rules – In an article on GovExec.com, Eric Katz explained how in a recent precedential decision the Federal Circuit decided that dismissal of federal employees “does not require a special procedure.”

VirnetX Attacks Apple’s PTAB Win At Fed. Circ. – Andrew Karpan reported for Law360 on VirnetX’s attempt to overturn a Patent Trial and Appeal Board ruling that if affirmed would undermine its $576 million patent infringement judgment against Apple.

Marathon, Others Defend Patent Case Fee Award at Federal Circuit – In her article on Bloomberg.com, Perry Cooper discusses a three judge panel of the Federal Circuit who “listened to arguments about a $5 million attorneys’ fee award in a fracking patent case.”

Last Week in the Federal Circuit (June 1-4): Prosecution Disclaimer – What’s Good for the Goose… – In this post on FederalCircuitry, Rachel Rice picked opinions released by the Federal Circuit that have “piqued [her] interest” to discuss.

Fed. Circ. Won’t Make Albright Rebuke Precedential – Adam Lidgett on Law360 reported on how the Federal Circuit stated it will not “reissue as precedential a March decision rebuking Judge Alan Albright for repeatedly failing to rule on transfer motions in a timely manner.”

After Hyatt v. Hirshfeld, it Might Be Time to Pay Attention to Prosecution Laches – Kate Gaudry recently posted on IPWatchDog.com about the repercussions of Hyatt v. Hirshfeld and prosecution laches for attorneys.

Amazon, Macy’s, Dell, Others Free From Patent Infringement Suit – Perry Cooper, a legal reporter for BloombergLaw.com, reported on the aftermath of a recent decision made by the Federal Circuit in SpeedTrack, Inc. v. Amazon.com.

Here is the latest.